In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

No. 13-883V 

(Not to be published)

* * * * * * * * * * * * * * * * * * * * * * * * * * * * * 

 * 

DOUGLAS D. NICHOLS, * 

 * 

 Petitioner, * Filed: March 23, 2015 

 * 

 v. * Decision by Stipulation; Damages; 

 * Influenza (“Flu”) Vaccine; 

 * Guillain-Barré Syndrome (“GBS”) 

SECRETARY OF HEALTH AND * 

HUMAN SERVICES, * 

 * 

 Respondent. * 

 * 

* * * * * * * * * * * * * * * * * * * * * * * * * * * * * 

Diana Sedar, Maglio, Christopher and Toale, PA, Sarasota, FL, for Petitioner. 

Alexis Babcock, U.S. Dep’t of Justice, Washington, DC, for Respondent 

DECISION AWARDING DAMAGES1

On November 8, 2013, Douglas Nichols filed a petition seeking compensation under the 

National Vaccine Injury Compensation Program (the “Vaccine Program”).2 Petitioner alleges

that he suffered Guillain-Barré syndrome (“GBS”) and related complications as a result of 

receiving an influenza (“flu”) vaccine. 

1 Because this decision contains a reasoned explanation for my action in this case, I will post this decision on the 

United States Court of Federal Claims’ website, in accordance with the E-Government Act of 2002, Pub. L. No. 

107-347, § 205, 116 Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501 note (2006)). As provided by 42 

U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the posted decision’s inclusion of certain kinds of 

confidential information. Specifically, under Vaccine Rule 18(b), each party has 14 days within which to request 

redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in 

substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which 

would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole decision will 

be available to the public. (Id.) 

2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine 

Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 42 U.S.C.A. ' 300aa-10-' 300aa-34 

(West 1991 & Supp. 2002). All citations in this decision to individual sections of the Vaccine Act are to 42 U.S.C.A. 

' 300aa.

 
Respondent denies that Petitioner’s GBS and any related medical problems were caused 

by the receipt of the flu vaccine. Nonetheless both parties, while maintaining their above-stated 

positions, agreed in a stipulation filed March 23, 2015 that the issues before them can be settled 

and that a decision should be entered awarding Petitioner compensation. 

I have reviewed the file, and based upon that review, I conclude that the parties’

stipulation is reasonable. I therefore adopt it as my decision in awarding damages on the terms 

set forth therein. 

The stipulation awards: 

(a) A lump sum of $60,000.00, in the form of a check payable to Petitioner. This 

amount represents compensation for all damages that would be available under 

42 U.S.C. § 300aa-15(a); and

(b) A lump sum of $1,556.10 representing compensation for satisfaction of the 

State of Florida Medicaid lien, payable jointly to the Petitioner and 

Xerox Recovery Services

P.O. Box 12188 

Tallahassee, FL 32317-2188 

Attn: April Baucham

Petitioner agrees to endorse this payment to Xerox Recovery Services.

Stipulation ¶ 8. 

I approve a Vaccine Program award in the requested amount set forth above to be made 

to Petitioner. In the absence of a motion for review filed pursuant to RCFC Appendix B, the 

clerk of the court is directed to enter judgment herewith.3

IT IS SO ORDERED.

 /s/ Brian H. Corcoran

Brian H. Corcoran 

Special Master

3 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by jointly filing notice renouncing 

their right to seek review.

2